Biopolio B1/3

Biopolio B1/3 Oral Vaccine contains live attenuated poliovirus (strain types 1, 2 and 3) and is intended for polio prophylaxis in infants 6-12 weeks of age, all unimmunized children up to 18 years of age and high-risk adults. Adults, however, should receive the inactivated poliovirus vaccine (IPV).

Polio vaccines are vaccines used to prevent poliomyelitis (polio). There are two types of polio vaccines, one is inactivated poliovirus vaccine (IPV) which is given by injection and the other is weakened oral poliovirus vaccine(OPV) given by mouth.

Yes, polio virus attacks the nervous system which can lead to paralysis, especially of lower limbs. Therefore, it is important to get Biopolio B1/3 Oral Vaccine as it provides protection against this virus.

No, IPV is considered more effective than Biopolio B1/3 Oral Vaccine. Although, it is expensive and relatively difficult to administer. It was seen that giving Biopolio B1/3 Oral Vaccine alone led to more cases of polio when compared to Biopolio B1/3 Oral Vaccine because it is a live form of the virus. Therefore, in order to prevent polio outbreaks, Biopolio B1/3 Oral Vaccine is the preferred form of polio vaccine.